• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中心血管磁共振腺苷负荷诱导的心肌灌注缺损的患病率及临床意义

Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.

作者信息

Kim Eun Kyoung, Lee Sang-Chol, Chang Sung-A, Jang Shin-Yi, Kim Sung Mok, Park Sung-Ji, Choi Jin-Oh, Park Seung Woo, Jeon Eun-Seok, Choe Yeon Hyeon

机构信息

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, #81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

Department of Radiology and Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

出版信息

J Cardiovasc Magn Reson. 2020 May 4;22(1):30. doi: 10.1186/s12968-020-00623-1.

DOI:10.1186/s12968-020-00623-1
PMID:32366254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7199346/
Abstract

BACKGROUND

Hypertrophic cardiomyopathy (HCM) is thought to be associated with microvascular dysfunction. Adenosine stress-perfusion cardiovascular magnetic resonance imaging (CMR) is a sensitive method for assessing microvascular perfusion abnormalities. We evaluated the prevalence and clinical characteristics of HCM patients with adenosine-induced perfusion defects on CMR.

METHODS

Among 189 consecutive patients with HCM who underwent adenosine-stress perfusion CMR, 115 patients who had clinical, echocardiography, 24-h Holter monitoring and treadmill exercise test data were analyzed. We calculated myocardial perfusion ratio index from the intensity-over-time curve to quantify perfusion defects. The presence and extent of the stress-induced perfusion defect were compared with clinical characteristics, presence and extent of late gadolinium enhancement (LGE), left ventricular (LV) mass index and volume, presence of non-sustained ventricular tachycardia (NSVT) and results of treadmill exercise test.

RESULTS

The mean age of enrolled patients was 51.8 ± 11.3 years. Most patients were asymptomatic except 25 subjects presented with New York Heart Association Class II dyspnea and 16 patients with atypical non-exertional chest discomfort. LGE was present in 103 (89.6%) subjects. Adenosine stress-induced perfusion defects were present in 48 (42%) subjects. None of the perfusion defects corresponded with a single or multiple coronary artery territories, showing a multiple patchy pattern in 24 (50.0%), a concentric subendocardial pattern in 20 subjects (41.7%), and as a single blot-like defect in the remaining 4 (8.3%). A perfusion defect was associated with NSVT, LV apical aneurysm, higher LV mass index, and higher LGE volume on univariate analysis. Multivariate analysis revealed female gender (P = 0.008), presence of apical aneurysm and NSVT (P = 0.036 and 0.047, respectively), and LV mass index (P = 0.022) to be independently associated with adenosine stress-induced perfusion defects.

CONCLUSIONS

In patients with HCM, adenosine-stress perfusion defects on CMR are present in more than 40% of subjects. This perfusion defect is associated with NSVT, higher LV mass index, and apical aneurysms. The prognostic value of this finding needs further elucidation.

摘要

背景

肥厚型心肌病(HCM)被认为与微血管功能障碍有关。腺苷负荷灌注心血管磁共振成像(CMR)是评估微血管灌注异常的一种敏感方法。我们评估了CMR上出现腺苷诱导灌注缺损的HCM患者的患病率及临床特征。

方法

在189例连续接受腺苷负荷灌注CMR的HCM患者中,分析了115例有临床、超声心动图、24小时动态心电图监测及平板运动试验数据的患者。我们从强度-时间曲线计算心肌灌注比指数以量化灌注缺损。将负荷诱导的灌注缺损的存在情况及范围与临床特征、延迟钆增强(LGE)的存在情况及范围、左心室(LV)质量指数和容积、非持续性室性心动过速(NSVT)的存在情况以及平板运动试验结果进行比较。

结果

入选患者的平均年龄为51.8±11.3岁。除25例出现纽约心脏协会II级呼吸困难和16例出现非劳力性非典型胸痛的患者外,大多数患者无症状。103例(89.6%)患者存在LGE。48例(42%)患者存在腺苷负荷诱导的灌注缺损。没有一个灌注缺损与单一或多个冠状动脉区域相对应,24例(50.0%)表现为多发斑片状,20例(41.7%)表现为同心内膜下型,其余4例(8.3%)表现为单个斑点状缺损。单因素分析显示灌注缺损与NSVT、左心室心尖部动脉瘤、较高的左心室质量指数及较高的LGE容积相关。多因素分析显示女性(P = 0.008)、心尖部动脉瘤和NSVT的存在(分别为P = 0.036和0.047)以及左心室质量指数(P = 0.022)与腺苷负荷诱导的灌注缺损独立相关。

结论

在HCM患者中,超过40%的患者CMR上存在腺苷负荷灌注缺损。这种灌注缺损与NSVT、较高的左心室质量指数及心尖部动脉瘤相关。这一发现的预后价值需要进一步阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/3088bb62cc0f/12968_2020_623_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/427f16c515a2/12968_2020_623_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/72d6dc20b843/12968_2020_623_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/ef16b30c7cff/12968_2020_623_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/ff61a6cb8dd6/12968_2020_623_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/3088bb62cc0f/12968_2020_623_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/427f16c515a2/12968_2020_623_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/72d6dc20b843/12968_2020_623_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/ef16b30c7cff/12968_2020_623_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/ff61a6cb8dd6/12968_2020_623_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b88/7199346/3088bb62cc0f/12968_2020_623_Fig5_HTML.jpg

相似文献

1
Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.肥厚型心肌病中心血管磁共振腺苷负荷诱导的心肌灌注缺损的患病率及临床意义
J Cardiovasc Magn Reson. 2020 May 4;22(1):30. doi: 10.1186/s12968-020-00623-1.
2
3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.3.0 T磁共振心肌灌注成像用于肥厚型心肌病冠状动脉微血管功能障碍的半定量评估
Int J Cardiovasc Imaging. 2017 Dec;33(12):1949-1959. doi: 10.1007/s10554-017-1189-9. Epub 2017 Jun 13.
3
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.肥厚型心肌病心力衰竭的心血管磁共振预测因子:心肌替换纤维化和微循环的作用。
J Cardiovasc Magn Reson. 2021 Mar 8;23(1):26. doi: 10.1186/s12968-021-00720-9.
4
The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.肥厚型心肌病患者延迟钆增强磁共振与非持续室性心动过速负荷的关系:一项延迟对比增强磁共振研究。
J Cardiovasc Electrophysiol. 2019 May;30(5):651-657. doi: 10.1111/jce.13855. Epub 2019 Feb 2.
5
Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.腺苷负荷心脏磁共振 T1 mapping 检测 2 型糖尿病无阻塞性冠状动脉疾病患者的早期微血管功能障碍。
J Cardiovasc Magn Reson. 2017 Oct 25;19(1):81. doi: 10.1186/s12968-017-0397-8.
6
Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?负荷灌注成像能否提高延迟钆增强心脏磁共振成像对心力衰竭病因诊断的准确性?
BMC Cardiovasc Disord. 2017 Apr 8;17(1):98. doi: 10.1186/s12872-017-0529-y.
7
Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.直线灌流绘图提供了对肥厚型心肌病发病机制的深入了解。
Heart. 2020 Jun;106(11):824-829. doi: 10.1136/heartjnl-2019-315848. Epub 2019 Dec 10.
8
Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.扩张型心肌病的微血管功能障碍:一项定量应激灌注心血管磁共振研究。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1699-1708. doi: 10.1016/j.jcmg.2018.10.032. Epub 2019 Jan 16.
9
Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.通过心脏磁共振成像定量的心肌灌注储备与肥厚型心肌病的延迟钆增强相关。
Heart Vessels. 2018 May;33(5):513-520. doi: 10.1007/s00380-017-1088-y. Epub 2017 Nov 22.
10
High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.T2加权心脏磁共振成像上的高信号强度与肥厚型心肌病中的室性快速性心律失常相关。
Heart Vessels. 2013 Nov;28(6):742-9. doi: 10.1007/s00380-012-0300-3. Epub 2012 Oct 25.

引用本文的文献

1
Feasibility and Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients With End-Stage Renal Disease.终末期肾病患者应激心血管磁共振成像的可行性及预后价值
JACC Adv. 2025 Jul 28;4(8):102008. doi: 10.1016/j.jacadv.2025.102008.
2
Prognostic Value of Coronary Angiography-Derived Index of Microvascular Resistance in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者冠状动脉造影衍生微血管阻力指数的预后价值
MedComm (2020). 2025 Jul 25;6(8):e70289. doi: 10.1002/mco2.70289. eCollection 2025 Aug.
3
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.

本文引用的文献

1
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.肥厚型心肌病 NHLBI 登记处的不同亚组。
J Am Coll Cardiol. 2019 Nov 12;74(19):2333-2345. doi: 10.1016/j.jacc.2019.08.1057.
2
The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.钆延迟增强的程度优于当前指南推荐标准,可用于识别肥厚型心肌病患者中存在心源性猝死风险的患者。
J Cardiovasc Magn Reson. 2019 Aug 15;21(1):50. doi: 10.1186/s12968-019-0561-4.
3
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy.
心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
4
The Role of Cardiovascular Magnetic Resonance Imaging in Athletic Individuals-A Narrative Review.心血管磁共振成像在运动员中的作用——一篇叙述性综述
J Clin Med. 2025 May 20;14(10):3576. doi: 10.3390/jcm14103576.
5
Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-Depth Review of Techniques and Clinical Applications.非缺血性心肌病的心血管磁共振心肌灌注成像:技术与临床应用的深入综述
Medicina (Kaunas). 2025 May 10;61(5):875. doi: 10.3390/medicina61050875.
6
The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy.心脏磁共振成像在肥厚型心肌病管理中的作用
J Cardiovasc Dev Dis. 2025 May 15;12(5):189. doi: 10.3390/jcdd12050189.
7
High altitudes, deeper insights: multicenter cardiovascular magnetic resonance study on hypertrophic cardiomyopathy.高海拔地区,深入洞察:肥厚型心肌病的多中心心血管磁共振研究
Eur Radiol. 2024 Dec 31. doi: 10.1007/s00330-024-11305-2.
8
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations in patients with congenital heart disease.心血管磁共振学会关于先天性心脏病患者心血管磁共振检查报告的指南。
J Cardiovasc Magn Reson. 2024;26(2):101062. doi: 10.1016/j.jocmr.2024.101062. Epub 2024 Jul 23.
9
Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance.通过造影衍生的微血管阻力评估胸痛型肥厚型心肌病的微血管功能障碍。
Sci Rep. 2024 Jul 23;14(1):16977. doi: 10.1038/s41598-024-67979-7.
10
Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.梗阻性肥厚型心肌病经皮心内间隔射频消融术后心肌灌注改善及机制:心肌对比超声心动图研究
Int J Cardiovasc Imaging. 2024 Jul;40(7):1483-1492. doi: 10.1007/s10554-024-03126-7. Epub 2024 May 6.
梗阻性与终末期肥厚型心肌病患者心室内冠状动脉重构与心肌纤维化的组织病理学比较。
Int J Cardiol. 2019 Sep 15;291:77-82. doi: 10.1016/j.ijcard.2019.03.060. Epub 2019 Mar 28.
4
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.肥厚型心肌病伴收缩功能保留患者的晚期钆增强。
J Am Coll Cardiol. 2018 Aug 21;72(8):857-870. doi: 10.1016/j.jacc.2018.05.060.
5
Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.肥厚型心肌病患儿和青少年中晚期钆增强的发生率和进展情况。
Circulation. 2018 Aug 21;138(8):782-792. doi: 10.1161/CIRCULATIONAHA.117.032966.
6
Women with hypertrophic cardiomyopathy have worse survival.患有肥厚型心肌病的女性患者生存率较差。
Eur Heart J. 2017 Dec 7;38(46):3434-3440. doi: 10.1093/eurheartj/ehx527.
7
Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.心肌磁共振分析区域性和弥漫性间质纤维化的组织学验证。
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):14-22. doi: 10.1093/ehjci/jeu182. Epub 2014 Oct 28.
8
Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.肥厚型心肌病中的冠状动脉微血管缺血——一项逐像素定量心血管磁共振灌注研究
J Cardiovasc Magn Reson. 2014 Aug 12;16(1):49. doi: 10.1186/s12968-014-0049-1.
9
Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.肥厚型心肌病患者年龄<20 岁时钆延迟增强的临床意义。
Am J Cardiol. 2014 Apr 1;113(7):1234-9. doi: 10.1016/j.amjcard.2013.12.034. Epub 2014 Jan 15.
10
Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者在血管扩张剂应激时心肌氧合反应迟钝。
J Am Coll Cardiol. 2013 Mar 19;61(11):1169-76. doi: 10.1016/j.jacc.2012.12.024.